Here we measured serum soluble TGF‐β (sTGF‐β) levels and evaluated its dynamics and prognostic capabilities during chemotherapy in unresectable pancreatic cancer patients. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.